Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On

Endovia Health Sciences, Inc. (NYSE: EDVA) saw its stock price increase by 47.83% to $0.34 in after-hours trading following the completion of the first tranche of funding from C/M Capital Master Fund, LP. This funding is part of a larger investment commitment related to Endovia's exclusive global licensing agreement for CannEpil with Argent BioPharma Limited, aimed at advancing the development of CannEpil for cancer-related pain in companion animals. The company's market capitalization is approximately $1.61 million, and it has experienced a significant decline of 97.37% over the past year.